Keyphrases
Multiple Sclerosis
100%
Murine Model
100%
Xanthine Oxidase
100%
Axonal Loss
100%
Myelin Loss
100%
Febuxostat
66%
Experimental Autoimmune Encephalomyelitis
55%
Reactive Oxygen Species
44%
Experimental Autoimmune Encephalomyelitis Mice
33%
In Vitro Study
22%
Xanthine Oxidase Inhibitor
22%
Inflammation
11%
Oxidative Stress
11%
Central Nervous System
11%
Therapeutic Potential
11%
Microglia
11%
Therapeutic Efficacy
11%
Reactive Oxygen Species Production
11%
Spinal Cord
11%
Nave
11%
Infiltrating Macrophages
11%
New Therapies
11%
Multiple Sclerosis Treatment
11%
Prophylactic Administration
11%
Neuropathology
11%
Clinical Signs
11%
Cell Infiltration
11%
Secondary Progressive
11%
Glial Activation
11%
Axonal Demyelination
11%
Chronic Relapsing Experimental Autoimmune Encephalomyelitis
11%
Neuroscience
Myelin
100%
Multiple Sclerosis
100%
Experimental Autoimmune Encephalomyelitis
100%
Xanthine Oxidase
100%
Febuxostat
66%
Reactive Oxygen Species
55%
In Vitro
22%
Xanthine Oxidase Inhibitor
22%
In Vivo
11%
Central Nervous System
11%
Macrophage
11%
Oxidative Stress
11%
Microglia
11%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
100%
Xanthine Oxidase
100%
Experimental Autoimmune Encephalomyelitis
100%
Myelin
100%
Febuxostat
66%
Reactive Oxygen Metabolite
55%
Xanthine Oxidase Inhibitor
22%
Inflammation
11%
Combination Therapy
11%
Demyelination
11%
Immunology and Microbiology
Experimental Autoimmune Encephalomyelitis
100%
Multiple Sclerosis
100%
Myelin
100%
Febuxostat
66%
Oxidative Stress
11%
Macrophage
11%
Microglia
11%
Central Nervous System
11%
Spinal Cord
11%